General Information of Drug Off-Target (DOT) (ID: OT9IHH51)

DOT Name ER membrane protein complex subunit 6 (EMC6)
Synonyms Transmembrane protein 93
Gene Name EMC6
Related Disease
Cervical cancer ( )
Cervical carcinoma ( )
Cervical Intraepithelial neoplasia ( )
Gastric adenocarcinoma ( )
Adult glioblastoma ( )
Glioblastoma multiforme ( )
Neoplasm ( )
UniProt ID
EMC6_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
6WW7; 6Z3W; 7ADO; 7ADP; 8EOI; 8S9S
Pfam ID
PF07019
Sequence
MAAVVAKREGPPFISEAAVRGNAAVLDYCRTSVSALSGATAGILGLTGLYGFIFYLLASV
LLSLLLILKAGRRWNKYFKSRRPLFTGGLIGGLFTYVLFWTFLYGMVHVY
Function
Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes (Probable).

Molecular Interaction Atlas (MIA) of This DOT

7 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cervical cancer DISFSHPF Strong Biomarker [1]
Cervical carcinoma DIST4S00 Strong Biomarker [1]
Cervical Intraepithelial neoplasia DISXP757 Strong Biomarker [1]
Gastric adenocarcinoma DISWWLTC Strong Altered Expression [2]
Adult glioblastoma DISVP4LU moderate Biomarker [3]
Glioblastoma multiforme DISK8246 moderate Biomarker [3]
Neoplasm DISZKGEW moderate Biomarker [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of ER membrane protein complex subunit 6 (EMC6). [4]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of ER membrane protein complex subunit 6 (EMC6). [5]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of ER membrane protein complex subunit 6 (EMC6). [6]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of ER membrane protein complex subunit 6 (EMC6). [7]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of ER membrane protein complex subunit 6 (EMC6). [9]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of ER membrane protein complex subunit 6 (EMC6). [8]
------------------------------------------------------------------------------------

References

1 Expression levels and roles of EMC-6, Beclin1, and Rab5a in the cervical cancer.Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):3038-3046.
2 ER membrane protein complex subunit 6 (EMC6) is a novel tumor suppressor in gastric cancer.BMB Rep. 2017 Aug;50(8):411-416. doi: 10.5483/bmbrep.2017.50.8.065.
3 EMC6/TMEM93 suppresses glioblastoma proliferation by modulating autophagy.Cell Death Dis. 2016 Jan 14;7(1):e2043. doi: 10.1038/cddis.2015.408.
4 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
7 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.